Design and Manufacture of Nonelectronic, Active-Infusion Patch and Device for Transdermal Delivery Across Skin
First Claim
Patent Images
1. A transdermal patch device comprising:
- a body piece having a proximal side and a distal side;
an activator access in the body piece;
an actuator compartment within the body piece and operably connected with the activator access;
a drug reservoir at a proximal side of the body piece, a distal side of the drug reservoir adjacent a proximal side of the actuator compartment; and
a transdermal drug delivery zone at a proximal side of the drug reservoir;
wherein in an initial, pre-activated state, actuator within the actuator compartment is isolated from an activator;
wherein, upon initiation by a user, an activator transits through the activator access into the actuator compartment and contacts the actuator, causing the actuator to swell, whereby the actuator expands in a proximal direction and thereby transmits force to the distal side of the drug reservoir, whereby a drug in the drug reservoir is forced through the transdermal drug delivery zone and out of the device.
1 Assignment
0 Petitions
Accused Products
Abstract
Transdermal patches and devices for delivery of therapeutic drug and/or cosmetic formulations through an intact or porated skin barrier are described. Active-infusion delivers controlled dosing over a period of time to provide long-term efficacy. Methods and devices for preparing active-infusion patches for controlled dose delivery by nonelectronic means and methods of skin poration that is safe and painless are described.
-
Citations
20 Claims
-
1. A transdermal patch device comprising:
-
a body piece having a proximal side and a distal side; an activator access in the body piece; an actuator compartment within the body piece and operably connected with the activator access; a drug reservoir at a proximal side of the body piece, a distal side of the drug reservoir adjacent a proximal side of the actuator compartment; and a transdermal drug delivery zone at a proximal side of the drug reservoir; wherein in an initial, pre-activated state, actuator within the actuator compartment is isolated from an activator; wherein, upon initiation by a user, an activator transits through the activator access into the actuator compartment and contacts the actuator, causing the actuator to swell, whereby the actuator expands in a proximal direction and thereby transmits force to the distal side of the drug reservoir, whereby a drug in the drug reservoir is forced through the transdermal drug delivery zone and out of the device. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification